Maternity

[Press Release] Abortion: Genuine Prevention Policy Urgently Needed

Alliance VITA has renewed its request for the new French government to develop a genuine abortion prevention and provide more balanced information for women with unplanned pregnancies. With more than 200,000 abortions performed annually, France has one of the highest...

Contraception, sterilization: women fighting for health issues

On Monday, September 18, 2017, the Bayer laboratory announced that it will stop selling its sterilization implant Essure® in Europe. The controversy surrounding the device has lasted several months, following lawsuits filed by numerous women claiming the implant...

NSERM Research: Improvements for Preterm Infants

Recently the British Medical Journal published the results of INSERM’s « EPIPAGE-2 » research study which demonstrated that in the past 20 years, preterm infants live longer and have fewer complications. The EPIPAGE-2 research team studied over 5,500 infants born...

Number of abortions in France remains high for 2016

On June 26, the service in charge of statistics at the French National Health Ministry (the “Drees”) published the abortion statistics in France for 2016, noting a slight decrease. Although there has been a slight decline these past 3 years, the number of abortions...

Preventing Abortion in Europe 

On June 22, 2017, Alliance VITA participated in the international seminar on « Preventing Abortion in Europe, Legal Framework and Social Policies”, which was organized by the European Centre for Law & Justice (ECLJ) in Brussels. Every year, 4 million European...

Over-the-Counter Access for Birth Control Pills: What’s the Rush?

On April 17, 2017, a French group called « Libérez ma pilule” : (Free the Pill) published an open letter addressed to pharmaceutical labs, the French Health Products Safety Agency and the European Medical Agency (EMA), to request OTC (over-the counter) marketing of...